AU2664999A - Human channel-related molecules - Google Patents

Human channel-related molecules

Info

Publication number
AU2664999A
AU2664999A AU26649/99A AU2664999A AU2664999A AU 2664999 A AU2664999 A AU 2664999A AU 26649/99 A AU26649/99 A AU 26649/99A AU 2664999 A AU2664999 A AU 2664999A AU 2664999 A AU2664999 A AU 2664999A
Authority
AU
Australia
Prior art keywords
related molecules
human channel
human
channel
molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU26649/99A
Inventor
Janice Au-Young
Olga Bandman
Mariah R. Baughn
Neil C. Corley
Preeti Lal
Y. Tom Tang
Henry Yue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Incyte Corp
Original Assignee
Incyte Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Incyte Pharmaceuticals Inc filed Critical Incyte Pharmaceuticals Inc
Publication of AU2664999A publication Critical patent/AU2664999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
AU26649/99A 1998-02-25 1999-02-08 Human channel-related molecules Abandoned AU2664999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US3074798A 1998-02-25 1998-02-25
US09030747 1998-02-25
PCT/US1999/002739 WO1999043807A2 (en) 1998-02-25 1999-02-08 Human channel-related molecules

Publications (1)

Publication Number Publication Date
AU2664999A true AU2664999A (en) 1999-09-15

Family

ID=21855815

Family Applications (1)

Application Number Title Priority Date Filing Date
AU26649/99A Abandoned AU2664999A (en) 1998-02-25 1999-02-08 Human channel-related molecules

Country Status (5)

Country Link
EP (1) EP1056853A2 (en)
JP (1) JP2002504368A (en)
AU (1) AU2664999A (en)
CA (1) CA2321667A1 (en)
WO (1) WO1999043807A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054378A1 (en) * 2000-10-27 2002-05-02 Mannesmann Ag Procedure for collecting user fees
WO2008013816A2 (en) * 2006-07-24 2008-01-31 Thallion Pharmaceuticals, Incorporated Tat-051 and methods of assessing and treating cancer

Also Published As

Publication number Publication date
WO1999043807A3 (en) 1999-12-16
EP1056853A2 (en) 2000-12-06
CA2321667A1 (en) 1999-09-02
WO1999043807A2 (en) 1999-09-02
JP2002504368A (en) 2002-02-12

Similar Documents

Publication Publication Date Title
AU3485999A (en) Neo-tryptophan
AU9392998A (en) Pack-a-pillow
AU5970699A (en) Use
AU3437799A (en) City-car
AU3522399A (en) Carvedilol-galenics
AU2587399A (en) Human transport-associated molecules
AU3253699A (en) Myxochelines
AU5407599A (en) Sphingolipid-desaturase
AU3668499A (en) Human receptor molecules
AU8363398A (en) Capotasto
AU2609599A (en) Sensor-coupling
AU2227999A (en) Human ependymin
AU3204999A (en) Futureball
AU2069199A (en) Codelets
AU2664999A (en) Human channel-related molecules
AU1055399A (en) Rollerboard
AU2202100A (en) Human brainiac-5
AU2591099A (en) Human proteinase molecules
AU5223199A (en) Bathtub-bathseat
AU3347599A (en) Aeromobile
AU9347498A (en) Imidazotriazolopyrimidines
AU2840799A (en) 1-phosphanorbornadienes
AU3819799A (en) Methoximinomethyloxathiazines
AU2875299A (en) Convenience apparatus
AU9218098A (en) Exocyclic-phosphoethanolamines

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase